corona-virus kandidat

siehe auch News
Aktie US Pre-Market1.21 (13.99%)

* Shares of diagnostics company rise 13% to $9.78 in extended trading

** Co forecasts FY revenue between $96 mln and $100 mln, above analysts' expectation of $95.22 mln - Refinitiv IBES
** Expects FY diluted EPS between $1.07 and $1.16 vs estimates of $0.98
** Co says Q3 revenue rose 30% to $30.1 mln primarily due to sales of its Logix Smart COVID-19 test

** Two of three brokerages rate the stock "buy" or higher and one "hold"; their median PT is $22.50

** Up to Thursday's close, stock has lost ~7% YTD

(Reporting by Mrinalika Roy in Bengaluru) ((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223 8780, outside U.S. +91 806749 8325;))

1y Target Est  $ 22.50    (Yahoo)